UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Psychopharmacology, 2013-03, Vol.226 (2), p.189-200

2013

Link zum Volltext

Verfügbarkeit prüfen

Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study

PloS one, 2014-08, Vol.9 (8), p.e104175

2014

Link zum Volltext

Verfügbarkeit prüfen

Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis

Clinical therapeutics, 2012-02, Vol.34 (2), p.363-373

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of nonmedical methamphetamine use in the United States

Substance abuse treatment, prevention and policy, 2008-07, Vol.3 (1), p.19-19, Article 19

2008

Link zum Volltext

Verfügbarkeit prüfen

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Journal of clinical psychopharmacology, 2013-02, Vol.33 (1), p.45-54

2013

Link zum Volltext

Verfügbarkeit prüfen

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies

The journal of clinical psychiatry, 2010-04, Vol.71 (4), p.451

2010

Link zum Volltext

Verfügbarkeit prüfen

Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: A pilot project

Journal of psychiatric research, 2014-07, Vol.54, p.11-18

2014

Link zum Volltext

Verfügbarkeit prüfen

Stimulant Formulation and Motivation for Nonmedical Use of Prescription Attention-Deficit/Hyperactivity Disorder Medications in a College-Aged Population

The American journal on addictions, 2010-11, Vol.19 (6), p.569-577

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder

Annals of clinical psychiatry, 2009-02, Vol.21 (1), p.26

2009

Link zum Volltext

Verfügbarkeit prüfen

Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of America

International clinical psychopharmacology, 2011-05, Vol.26 (3), p.141

2011

Link zum Volltext

Verfügbarkeit prüfen

Discriminative-Stimulus, Self-Reported, Performance, and Cardiovascular Effects of Atomoxetine in Methylphenidate-Trained Humans

Experimental and clinical psychopharmacology, 2006-05, Vol.14 (2), p.136-147

2006

Link zum Volltext

Verfügbarkeit prüfen

Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder

Journal of child and adolescent psychopharmacology, 2008-02, Vol.18 (1), p.44

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study

Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis

Prevalence of nonmedical methamphetamine use in the United States

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies

Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: A pilot project

Stimulant Formulation and Motivation for Nonmedical Use of Prescription Attention-Deficit/Hyperactivity Disorder Medications in a College-Aged Population

Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder

Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of America

Discriminative-Stimulus, Self-Reported, Performance, and Cardiovascular Effects of Atomoxetine in Methylphenidate-Trained Humans

Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder

Suchergebnisse filtern